Cymat Technologies (CYM) AI Stock Analysis

• Market Cap: C$11.05M
• Dividend Yield: N/A
• Average Volume (3M): 57.86K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.51
• Revenue Growth: -25.74%
• EPS Growth: 2.28%
• Country: CA
• Employees: 11
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Manufacturing - Metal Fabrication
• EPS (TTM): -0.01
• Shares Outstanding: 88,437,130
• 10 Day Avg. Volume: 33,999
• 30 Day Avg. Volume: 57,857
• PEG Ratio: 0.12
• Price to Book (P/B): -2.03
• Price to Sales (P/S): 2.58
• P/FCF Ratio: -5.85
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

Cymat Technologies faces significant financial and technical challenges. The company's financial performance is weak, with negative profitability and high leverage. Technical analysis indicates bearish market conditions, with the stock trading below key moving averages and showing oversold signals. Valuation metrics are also unfavorable, with a negative P/E ratio and no dividend yield. These factors collectively result in a low overall stock score.

Cymat Technologies Business Overview & Revenue Model

Company Description

Cymat Technologies is a Canadian company that specializes in advanced materials, particularly in the development and production of stabilized aluminum foam. The company operates primarily in the sectors of manufacturing and materials science, focusing on applications for its innovative products in construction, automotive, aerospace, and defense industries. Cymat's core offerings include its proprietary Alusion® material, which is known for its lightweight, energy absorption, and thermal insulation properties, providing unique solutions for various industrial applications.

How the Company Makes Money

Cymat Technologies generates revenue primarily through the sale of its Alusion® stabilized aluminum foam products to various industries, including construction, automotive, aerospace, and defense. The company capitalizes on its proprietary technology by licensing its manufacturing processes to partners, which provides a secondary revenue stream. Additionally, Cymat engages in strategic partnerships with companies within these sectors to enhance its market reach and product development, enabling it to secure contracts and expand its customer base. The company's earnings are also bolstered by ongoing research and development initiatives that aim to innovate and improve its product offerings, allowing it to meet the evolving needs of its clients.

Cymat Technologies Financial Statement Overview

Summary

Cymat Technologies is facing significant financial challenges across all major financial statements. The company is struggling with declining revenues, negative profitability, and high leverage. Cash flow issues persist despite some growth in free cash flow. Overall, the financial health of the company is concerning, with substantial risks due to operational inefficiencies and financial instability.

Income Statement

Cymat Technologies has faced significant challenges in its income statement metrics. The company has experienced declining revenue growth, with a negative growth rate in recent years. Profitability metrics such as gross profit margin and net profit margin are weak, indicating operational inefficiencies and high costs relative to revenue. The EBIT and EBITDA margins are also negative, reflecting ongoing operational losses.

Balance Sheet

The balance sheet reveals a concerning financial structure with negative stockholders' equity, indicating more liabilities than assets. The debt-to-equity ratio is negative, suggesting high leverage and financial instability. Return on equity is also negative, highlighting the company's inability to generate profits from shareholders' investments.

Cash Flow

Cash flow metrics show some improvement in free cash flow growth, but overall cash flow remains negative. The operating cash flow to net income ratio is negative, indicating cash flow issues relative to net income. The free cash flow to net income ratio is slightly positive, suggesting some ability to cover net losses with free cash flow, but overall cash flow health is weak.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2021	Dec 2021
Income Statement
Total Revenue	3.71M	3.71M	1.62M	3.05M	4.15M	3.12M
Gross Profit	494.39K	494.39K	-412.85K	-270.42K	2.12M	795.48K
EBITDA	-1.91M	-1.91M	-3.34M	-5.45M	252.17K	-4.23M
Net Income	-3.37M	-3.37M	-4.27M	-6.05M	-543.00K	-4.75M
Balance Sheet
Total Assets	2.76M	2.76M	3.96M	4.16M	6.58M	6.17M
Cash, Cash Equivalents and Short-Term Investments	354.03K	354.03K	56.27K	324.05K	5.02M	2.47M
Total Debt	5.58M	5.58M	2.94M	2.28M	1.10M	1.02M
Total Liabilities	7.49M	7.49M	6.78M	4.77M	3.71M	3.83M
Stockholders Equity	-4.73M	-4.73M	-2.81M	-612.07K	2.88M	2.34M
Cash Flow
Free Cash Flow	-1.64M	-1.64M	-2.26M	-3.49M	401.48K	-4.53M
Operating Cash Flow	-1.60M	-1.60M	-2.23M	-2.46M	432.92K	-4.32M
Investing Cash Flow	-37.52K	-37.52K	-31.32K	-1.03M	-31.44K	-534.54K
Financing Cash Flow	1.93M	1.93M	1.99M	1.18M	4.36M	2.30M

Cymat Technologies Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.12
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Neutral. The current price of 0.12 is above the 20-day moving average (MA) of 0.12, below the 50-day MA of 0.15, and below the 200-day MA of 0.14, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.52 is Neutral, neither overbought nor oversold. The STOCH value of 50.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CYM.

Cymat Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IVX	68 Neutral	C$3.70M	33.63	7.31%	―	35.07%	―
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DRX	60 Neutral	C$212.18M	6.30	22.54%	0.55%	-24.64%	-27.22%
IB	46 Neutral	C$26.32M	―	―	―	―	―
CYM	41 Neutral	C$11.05M	―	―	―	-25.74%	2.28%
IP	30 Underperform	$7.15M	―	―	―	-67.21%	―

Cymat Technologies Corporate Events

Cymat Technologies Announces Private Placement to Support Strategic Growth

Cymat Technologies has announced an update on its non-brokered private placement of equity Units, aiming to issue 11,934,615 Units for gross proceeds of $1,551,500. The proceeds will be used for capital equipment purchases and working capital to support a major strategic business development initiative. The offering is subject to TSX Venture Exchange approval and includes provisions to prevent the creation of new Insiders without necessary approvals. This move is expected to bolster Cymat’s operational capabilities and strategic positioning in its industry.

Cymat Technologies Completes $1.5 Million Private Placement to Boost Strategic Initiatives

Cymat Technologies Ltd. announced the completion of a $1.5 million private placement financing, issuing over 11 million common shares and warrants. The funds will support capital equipment purchases and strategic business initiatives, including a partnership with Rio Tinto Alcan and automotive projects, enhancing Cymat’s operational capabilities and market positioning.

Cymat Technologies Partners with Global Automotive Manufacturer

Cymat Technologies Ltd. has announced a partnership with a global Tier 1 automotive parts manufacturer to design and manufacture lightweight, energy-absorbing components for the automotive industry. This collaboration, alongside Tesseract Structural Innovations, Inc., aims to address the demand from a global automotive manufacturer. The partnership enables Cymat to leverage the manufacturing capabilities of its partner to assemble complex SAF-filled aluminum parts, enhancing its ability to secure automotive contracts and expand its market reach. This strategic move is expected to introduce Cymat’s innovative solutions to a broader range of automotive manufacturers, potentially strengthening its position in the industry.